So writes The New York Times, reporting today that the nation’s drug makers are prepping to pay more, under the Democrats’ final health reform bill, than the
“„As the health care bills move toward a House-Senate conference, the liberals appear poised to lose on so many other issues — including a proposed government-run insurer, a so-called Cadillac tax on expensive health plans and an independent Medicare-cutting commission — that the drug makers have come to accept that their deal may have to be modified, the lobbyists said.
“„Some industry lobbyists say the added costs could come to as much as $20 billion more.